SCHEMBL19330965

SCHEMBL19330965

CCOC(=O)c1cccc(C2(N)CCN(C(C)(C)C)CC2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ ALOX5 P09917 1/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ GRIN1 Q05586 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ GRIN3A Q8TCU5 1/20 0.42
▸ AKT1 P31749 1/20 0.41
▸ AKT2 P31751 1/20 0.41
▸ CYP4F2 P78329 1/20 0.41
▸ CYP4A11 Q02928 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19331376 0.84 TACR1 (0.43) SMN1; SMN2KDM4EATM
SCHEMBL8283182 0.83 HTR1A (0.50) SMN1; SMN2AKT1AKT2CYP4F2CYP4A11
SCHEMBL15054711 0.74 L3MBTL1 (0.46) SMN1; SMN2KDM4EATM
SCHEMBL19343286 0.73 KMT2A (0.53) OPRM1AKT1AKT2KDM4E
SCHEMBL5000848 0.72 SMN1; SMN2 (0.45) SMN1; SMN2CYP4F2CYP4A11ATM
SCHEMBL615716 0.72 SMN1; SMN2 (0.46) SMN1; SMN2ALOX5CYP4F2CYP4A11KDM4E
SCHEMBL1670244 0.71 LOXL2 (0.51) GRIN2DGRIN3BOPRM1GRIN1GRIN2A
SCHEMBL27699787 0.71 TP53 (0.47) SMN1; SMN2CYP4F2CYP4A11KDM4ENPC1
SCHEMBL19382551 0.71 SMN1; SMN2 (0.48) SMN1; SMN2ALOX5CYP4F2CYP4A11CDC25B
SCHEMBL16418421 0.70 OPRM1 (0.73) GRIN2DGRIN3BCHRM2CHRM1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426243-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF Raze Therapeutics Inc. (US) 2019-01-16 — — EP disclosed
WO-2017156165-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 — — WO disclosed
Send feedback